Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications.
about
Ablation of the Sam68 RNA binding protein protects mice from age-related bone lossOsteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathologyMetabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis ResearchDifferentiation of Bone Marrow Mesenchymal Stem Cells in Osteoblasts and Adipocytes and its Role in Treatment of OsteoporosisIntracellular VEGF regulates the balance between osteoblast and adipocyte differentiationRegulation of osteoblastogenesis and bone mass by Wnt10bId4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiationMetformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cellsBone marrow fat is increased in chronic kidney disease by magnetic resonance spectroscopy.Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylationEffects of GSK3 inhibitors on in vitro expansion and differentiation of human adipose-derived stem cells into adipocytesMechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation.Comparative transcriptomics of human multipotent stem cells during adipogenesis and osteoblastogenesisNuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiationHyperglycemia diverts dividing osteoblastic precursor cells to an adipogenic pathway and induces synthesis of a hyaluronan matrix that is adhesive for monocytesMicroRNAs and micromanaging the skeleton in disease, development and evolutionBone-marrow adipocytes as negative regulators of the haematopoietic microenvironmentDelayed fracture healing and increased callus adiposity in a C57BL/6J murine model of obesity-associated type 2 diabetes mellitus.Cellular basis for age-related changes in fracture repairGeneration of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes.Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone RegenerationEnhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients.Topics in transcriptional control of lipid metabolism: from transcription factors to gene-promoter polymorphisms.Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice.PPARĪ³ silencing enhances osteogenic differentiation of human adipose-derived mesenchymal stem cells.The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development.Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.Arginine enhances osteoblastogenesis and inhibits adipogenesis through the regulation of Wnt and NFATc signaling in human mesenchymal stem cells.Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastasesFoxo1, a novel regulator of osteoblast differentiation and skeletogenesisSonic Hedgehog influences the balance of osteogenesis and adipogenesis in mouse adipose-derived stromal cells.Anti-adipogenic and Pro-osteoblastogenic Activities of Spergularia marina ExtractOxytocin and boneEffect of Salicornia herbacea on osteoblastogenesis and adipogenesis in vitro.Osteoprotective effects of Fructus Ligustri Lucidi aqueous extract in aged ovariectomized rats.Regulation of early adipose commitment by Zfp521.The fat controller: adipocyte development.Adipogenesis and osteoblastogenesis: trans-differentiation in the pathophysiology of bone disorders.A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells.Hormone-sensitive lipase-knockout mice maintain high bone density during aging.
P2860
Q21145275-BD2620F2-CFA9-4D15-888B-FCF817DC9CC0Q27010162-2DB2705A-7DE4-4AEB-92F0-EED4E4D8BD9EQ28068862-8295DF3E-40E8-4754-8601-F91A1475578FQ28077985-DF268737-F968-483C-AD61-899EC8414EFDQ28504742-CC4317C3-6645-4CF1-8665-271CDDC55505Q28509048-C3CFE9AC-8613-4A5F-961D-5FE800CA14EFQ28513923-2028154D-43C6-49BD-9668-E25979B6FE17Q28566611-77AFF887-C623-4439-BD35-5498934EC38BQ30896537-08DFA241-748A-411C-8CF7-C0562FE20F9DQ31060276-469F73BF-1503-4088-A049-7929DF48348AQ33319636-AF845304-C89B-4573-BA3A-DDD06DDF53B8Q33325623-797BE7D6-3689-483F-BBB1-BA5315C41826Q33352850-D30EF452-8888-49A6-B51A-9FA3B2C2E9AFQ33563694-3BAF0E2D-31CA-4C3E-B539-D2D9FC26803FQ33676356-8EB33CCA-4573-4AA8-ACBC-D02CA283CF4BQ33689739-A357D75F-171E-4084-85B9-26498A04FF52Q33701168-2184050F-9425-4480-83ED-6345A030602EQ33727997-68CA5128-BCDA-45FE-90EB-1EC78B817822Q33749126-AFD69F55-B8EE-4163-BE0A-98568D09F8BAQ33749859-E6C6274D-24AA-4E92-8A54-A422F6611C41Q33765723-A84E4141-CA79-46F6-B150-B458AB8C6095Q33838933-57239FE7-7DBC-47D0-A969-C358CEBABF85Q33879733-A9620676-FBB3-4F10-BD8A-111DF890C396Q33951258-17734083-DC54-4990-A0F8-32929A0EC0F3Q33985647-871B0719-8A85-473D-A4B2-291955675FA3Q33987011-CD16CCAF-0CFD-4AB1-8C77-B436FB167771Q34063149-82E8966C-678F-4CC7-B91E-DE3FDE12D28DQ34072581-910339E0-E23C-41CF-A251-E5CDFD2C0C1FQ34132305-765F140A-68BD-4D44-B247-6D049B94DD93Q34155478-B47BE9F3-24EF-4888-BDDE-A2E5D3ED197BQ34163297-85E08553-4C7A-484C-90F1-8C330069CB97Q34331785-CCC4686B-7CB5-4224-8C36-9EF506959B0AQ34356431-5694DEC9-2BCD-4CED-B274-04ED7AF0F9CAQ34411516-79658305-C0AA-4803-A6C4-96F4E88E6835Q34412104-11CC2438-CC89-498B-B6A5-6FC99B312841Q34499279-972F20DF-28AC-4D5E-8DEA-1B5F8E5FE045Q34499285-6CEAC571-E9D0-4098-8B68-F523D0C49A50Q34976731-134C29E2-7832-4EF4-99AF-830045F5CB9DQ35095530-D5C6A8B3-558D-4EC1-A7D9-8396720C988DQ35105396-D20B5074-BC48-4415-8D7A-0D3F91912F54
P2860
Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications.
description
2004 nĆ® lÅ«n-bĆ»n
@nan
2004幓ć®č«ę
@ja
2004幓č«ę
@yue
2004幓č«ę
@zh-hant
2004幓č«ę
@zh-hk
2004幓č«ę
@zh-mo
2004幓č«ę
@zh-tw
2004幓č®ŗę
@wuu
2004幓č®ŗę
@zh
2004幓č®ŗę
@zh-cn
name
Controlling the balance betwee ...... uent therapeutic implications.
@ast
Controlling the balance betwee ...... uent therapeutic implications.
@en
type
label
Controlling the balance betwee ...... uent therapeutic implications.
@ast
Controlling the balance betwee ...... uent therapeutic implications.
@en
prefLabel
Controlling the balance betwee ...... uent therapeutic implications.
@ast
Controlling the balance betwee ...... uent therapeutic implications.
@en
P1476
Controlling the balance betwee ...... uent therapeutic implications.
@en
P2093
Jeffrey M Gimble
Mark E Nuttall
P304
P356
10.1016/J.COPH.2004.03.002
P577
2004-06-01T00:00:00Z